Statistics of Salvage use of allogeneic HSCT after reduced intensity conditioning from unrelated donors in multiple myeloma: outcomes from 10/10 HLA-matched unrelated donors, 9/10 HLA-mismatched unrelated donors and cord blood. A study by the EBMT and Eurocord
